We have written about the Ozempic-NAION side effect drug safety issue several times over the past year-and-a-half, and have repeatedly pointed out that NAION is linked to semaglutide, the active ingredient in the currently available Novo Nordisk semaglutide medicines: Ozempic injection, Wegovy … More
Main Navigation Menu
➤ Current Drug Injury Lawsuits / Pharmaceutical Litigations
➤ Drug Injury Case Evaluation – Free. Confidential. No Obligation.
➤ Information About the Law Offices of Thomas J. Lamb
➤ Questions New Clients Have Asked Us (FAQs)
➤ Patient Resources: Medical Sites and More
➤ Recent Side Effects Blog Articles
➤ Collection of Earlier Blog Articles
To save time, you can use our Quick Contact Form to tell us about your possible case.
Recent News & Case Reports
Ozempic NAION Risk 200% Higher Than Some Other Diabetes Drugs
The semaglutide-containing drug Ozempic has been linked to non-arteritic anterior ischemic optic neuropathy (NAION). A 2026 medical journal article reported that the Ozempic NAION risk 200% higher than that of some other diabetes drugs, such as Invokana (canagliflozin), Jardiance (empagliflozin), … More
Rybelsus Pancreatitis Warnings and Rybelsus Drug Injury Lawsuits
Rybelsus Pancreatitis Warnings In October 2025, warnings about pancreatitis were added to the Rybelsus “drug label”. Insofar as there were no Rybelsus pancreatitis warnings until October 2025, there is a possible “failure to warn” products liability claim for people who were diagnosed with Rybelsus … More
Depo-Provera Label Change In 2025 Added Meningioma Warning
In a significant development regarding warnings about side effects associated with Depo-Provera injections, an FDA-ordered change to the Depo-Provera drug label added a meningioma warning in December 2025. Put differently, before this Depo-Provera label change, there was no meningioma warning in … More
A Rybelsus Blood Clots DVT Case
We have been investigating Ozempic, Wegovy, and Rybelsus blood clots, deep vein thrombosis (DVT), and pulmonary embolism (PE) cases as possible drug injury lawsuits against the pharmaceutical company Novo Nordisk. Starting in or about 2021, Ozempic, Wegovy, and Rybelsus — the three Novo Nordisk … More
Mounjaro and Ozempic NAION Vision Loss Lawsuits: Federal Court MDL No. 3163
As seen elsewhere on this Drug Injury Law website, we have been investigating Mounjaro and Ozempic NAION vision loss lawsuits seeking legal compensation for the person suffering from this serious eye side effect injury: Zepbound and Mounjaro Eye Side Effect NAION Information Page Eye-related … More